Evidence map›Paper›PMID 30850438›Full record

ArticleJournal of the American Society of Nephrology : JASN2019

DNMT1 in

Szu-Yuan Li, Jihwan Park, Yuting Guan, Kiwung Chung, Rojesh Shrestha, Matthew B Palmer, Katalin Susztak

Abstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Epigenetic regulation of kidney development.Nature reviews. Nephrology · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. SLC39A8-mediated zinc dyshomeostasis potentiates kidney disease.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. The term CAKUT has outlived its usefulness: the case for the defense.Pediatric nephrology (Berlin, Germany) · 2022
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Szu-Yuan LiRenal-Electrolyte and Hypertension Division, Department of Medicine.
Jihwan ParkRenal-Electrolyte and Hypertension Division, Department of Medicine.ORCID 0000-0002-5728-912X
Yuting GuanRenal-Electrolyte and Hypertension Division, Department of Medicine.
Kiwung ChungRenal-Electrolyte and Hypertension Division, Department of Medicine.
Rojesh ShresthaRenal-Electrolyte and Hypertension Division, Department of Medicine.
Matthew B PalmerDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Katalin SusztakRenal-Electrolyte and Hypertension Division, Department of Medicine, ksusztak@pennmedicine.upenn.edu.ORCID 0000-0002-1005-3726
Gwangju Institute of Science and Technology · KRNational Yang Ming Chiao Tung University · TWUniversity of Pennsylvania · US

Funding

Role of the Notch Pathway in Kidney InjuryR01DK076077 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI KATALIN SUSZTAK · 2007 to 2026
$8.0M
Epigenetics of Chronic Kidney DiseaseR01DK087635 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI KATALIN SUSZTAK · 2009 to 2026
$7.0M
Epigenetic drivers and biomarkers of diabetic kidney diseaseDP3DK108220 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI SUSZTAK, KATALIN · 2015 to 2015
$2.4M
NIDDK NIH HHS DP3 DK108220NIDDK NIH HHS R01 DK076077NIDDK NIH HHS R01 DK087635
6 · The paper itself

Abstract

backgroundCytosine methylation of regulatory regions, such as promoters and enhancers, plays a key role in regulating gene expression, however, its role in kidney development has not been analyzed.

methodsTo identify functionally important epigenome-modifying enzymes and genome regions where methylation modifications are functionally important for kidney development, we performed genome-wide methylation analysis, expression profiling, and systematic genetic targeting of DNA methyltransferases (

resultsGenome-wide methylome analysis indicated dynamic changes on promoters and enhancers during development.

conclusionsGenome-wide cytosine methylation and gene expression profiling showed that by silencing embryonic, nonrenal lineage genes and transposable elements, DNMT1-mediated cytosine methylation is essential for kidney development.

Indexed as

DNA MethylationAnimalsDioxygenasesDNA-Binding ProteinsDNA (Cytosine-5-)-Methyltransferase 1DNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3ADNA Methyltransferase 3BDNA Transposable ElementsEnhancer Elements, GeneticEpigenomeGene ExpressionGene SilencingHomeodomain ProteinsKidneyMaleDioxygenasesDNA-Binding ProteinsDNA (Cytosine-5-)-Methyltransferase 1DNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3ADNA Methyltransferase 3BDNA Transposable ElementsDnmt1 protein, mouseDnmt3a protein, mouseHomeodomain ProteinsProto-Oncogene ProteinsRNA, ViralSix2 protein, mouseTet2 protein, mouseTranscription FactorsDNA methylationDNMTkidney developmentpodocyteTransposable element

Identifiers

PMID30850438
PMCPMC6442333
OpenAlexW2811061238

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.